Rare diseases
Investigational molecules
Locations
382 conditions with trials, the busiest first
846 trials across Europe, recruiting first
A study to test if tibulizumab works and is safe for adults with systemic sclerosis
HungaryStudy of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks
AustriaStudy of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients
AustriaStudy of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults
CzechiaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
AustriaStudy on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers
AustriaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
AustriaStudy on Dabigatran and Ticagrelor for Patients with Acute Coronary Syndrome and Atrial Fibrillation Undergoing Heart Procedure
PolandStudy on Rituximab and Cyclophosphamide for Treating ANCA-Associated Vasculitis in Patients Seeking Remission
PolandStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
BulgariaStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
BulgariaStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaThe therapies tested most often in Vascular disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
